Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cells.
The rapidly growing field of targeted tumor therapy often utilizes an antibody, sometimes tagged with a tumor-ablating material such as radioisotope, directed against a specific molecule.This report describes the discovery of nine novel decapeptides which can be radioactively labeled, bind to, and d...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-10-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1978517?pdf=render |